Pharmaceutical giants teaming up to Energize Clean Power Procurement across Supply Chains

Nov. 8, 2021
The firms participating in the Energize program will include AstraZeneca, Biogen, GSK, Johnson & Johnson, MDS, Novartis, Novo Nordisk, Pfizer, Sanofi and Takeda

Ten of the world’s largest pharmaceutical companies will collaborate on ways  to engage their suppliers in a vast decarbonization of the supply chain for the firms.

The firms participating in the Energize program will include AstraZeneca, Biogen, GSK, Johnson & Johnson, MDS, Novartis, Novo Nordisk, Pfizer, Sanofi and Takeda. The program will be designed and delivered by Schneider Electric.

Energize will be designed to assist pharmaceutical and health care suppliers to address their own operational greenhouse gas emissions through clean power procurement. Schneider Electric is also working with Carnstone, a management consulting firm which specializes in corporate responsibility and sustainability.

The program will initially focus on suppliers with energy load in Europe and North America, with the intention to expand globally where interest and renewable energy market opportunity align.

“Limiting global warming to safe levels will depend on moving the entire world to renewable energy. This is not something that companies can achieve on their own. We are strong believers in the power of collaboration, and are honored to be bringing the pharmaceutical industry together to drive the adoption of renewable energy in its supply chains,” said Glynn Roberts, Senior Partner, Carnstone.

The Energize program is designed to overcome typical market barriers such as inadequate knowledge about renewable energy transactions, load size, lack of credit, and the need for guidance throughout a complex and protracted contracting process. Participating suppliers will learn about the renewable energy market, receive guidance on PPAs, and have the opportunity to access and contract for renewable energy on their own or as part of a collaborative buyers’ cohort.